Cognition Therapeutics
(NASDAQ:CGTX)
$1.75
-0.09[-4.89%]
At close: Apr 19
$1.75
0[0.00%]
After Hours: 4:04PM EDT
Consensus Rating1
Buy
Highest Price Target1
$12.00
Lowest Price Target1
$5.00
Consensus Price Target1
$8.00

Cognition Therapeutics Stock (NASDAQ:CGTX), Analyst Ratings, Price Targets, Predictions

Cognition Therapeutics Inc has a consensus price target of $8, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from B. Riley Securities, Oppenheimer, and Ladenburg Thalmann on March 28, 2024, March 27, 2024, and August 14, 2023. With an average price target of $6.67 between B. Riley Securities, Oppenheimer, and Ladenburg Thalmann, there's an implied 280.95% upside for Cognition Therapeutics Inc from these 3 analyst ratings.

Analyst Trend
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B. Riley Securities
Oppenheimer
Ladenburg Thalmann
Cantor Fitzgerald

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Cognition Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/28/2024CGTXBuy Now
Cognition Therapeutics
$1.75185.71%B. Riley Securities
Mayank Mamtani
→ $5ReiteratesBuy → BuyGet Alert
03/27/2024CGTXBuy Now
Cognition Therapeutics
$1.75414.29%Oppenheimer
Jay Olson
$9 → $9MaintainsOutperformGet Alert
08/14/2023CGTXBuy Now
Cognition Therapeutics
$1.75242.86%Ladenburg Thalmann
Aydin Huseynov
$10 → $6MaintainsBuyGet Alert
05/09/2023CGTXBuy Now
Cognition Therapeutics
$1.75414.29%Oppenheimer
Jay Olson
→ $9Reiterates → OutperformGet Alert
03/24/2023CGTXBuy Now
Cognition Therapeutics
$1.75414.29%Oppenheimer
Jay Olson
→ $9Reiterates → OutperformGet Alert
09/29/2022CGTXBuy Now
Cognition Therapeutics
$1.75585.71%Cantor Fitzgerald
Charles Duncan
→ $12Initiates → OverweightGet Alert
04/22/2022CGTXBuy Now
Cognition Therapeutics
$1.75471.43%Ladenburg Thalmann
Aydin Huseynov
→ $10Initiates → BuyGet Alert
11/03/2021CGTXBuy Now
Cognition Therapeutics
$1.751157.14%Oppenheimer
Jay Olson
Initiates → OutperformGet Alert

FAQ

Q

What is the target price for Cognition Therapeutics (CGTX)?

A

The latest price target for Cognition Therapeutics (NASDAQ: CGTX) was reported by B. Riley Securities on March 28, 2024. The analyst firm set a price target for $5.00 expecting CGTX to rise to within 12 months (a possible 185.71% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cognition Therapeutics (CGTX)?

A

The latest analyst rating for Cognition Therapeutics (NASDAQ: CGTX) was provided by B. Riley Securities, and Cognition Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Cognition Therapeutics (CGTX)?

A

There is no last upgrade for Cognition Therapeutics.

Q

When was the last downgrade for Cognition Therapeutics (CGTX)?

A

There is no last downgrade for Cognition Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Cognition Therapeutics (CGTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cognition Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cognition Therapeutics was filed on March 28, 2024 so you should expect the next rating to be made available sometime around March 28, 2025.

Q

Is the Analyst Rating Cognition Therapeutics (CGTX) correct?

A

While ratings are subjective and will change, the latest Cognition Therapeutics (CGTX) rating was a reiterated with a price target of $0.00 to $5.00. The current price Cognition Therapeutics (CGTX) is trading at is $1.75, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch